drugset / Trial / NCT03248817

Phenylephrine Infusion in Cesarean Delivery

NCT03248817

Phase 4 Unknown 255 enrolled Cairo University
RandomizedParallel-groupTriple-blindPrevention

Summary

the investigators will compare variable infusion of phenylephrine (at a starting rate of 0.75 mcg/Kg/min) with fixed rate (0.75 mcg/Kg/min which will stop of reactive hypertension occurred) and single shot (1.5 mcg/Kg) phenylephrine

Timeline

Start
2017-09-28
Primary completion
2020-05-15
Completion
2020-05-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenylephrine Small molecule 0.75 ug/kg Intravenous
Subject Phenylephrine Small molecule 1.5 ug/kg Intravenous
Background Bupivacaine Other / unclassified Intrathecal

Indications

No indication recorded.